Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
6
×
national blog main
san diego blog main
6
×
san diego top stories
biotech
national top stories
new york blog main
boston blog main
boston top stories
new york top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
eli lilly
fda
investing
medicaid
medicare
san diego
abiraterone
What
year
6
×
drug
companies
disease
drugs
fda
medicines
new
plan
price
therapeutics
therapies
ago
akcea
alnylam
alzheimer’s
amyloidosis
answer
approval
approved
arguments
athena
attr
available
away
bacteria
battle
big
bio
biopharma
biotech
business
cancer
ceo
chief
class
commercialized
company
competitors
countouriotis
Language
unset
Current search:
year
×
" san diego blog main "
×
" life sciences "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push